Forecast & Rating3 analysts currently cover Cognition Therapeutics, of which 3 give a positive rating. The average price target is $3.33, about 237.7% upside from the current price of $0.99. Coverage is limited, so the data is for reference only. Data as of Aug 13, 2026; this does not constitute investment advice.
Aug 13, 2026Price forecast
$3.33237.72%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met5.6%
Stock price$0.99
Avg. target$3.5
High target$4
Low target$3
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.